News Tagged ‘carbamazepine

Taiwanese researchers pinpoint genetic marker for SJS

The serious adverse reaction to medication known as Stevens Johnson Syndrome, or , is rare in the U.S. and most countries, occurring in about one person per million each year. However, doctors at Chang Gung Memorial Hospital in Taipei, Taiwan, have seen as many as 40 to 50 cases of in only a year. “Sometimes we see two or three in a single week,” says Ghung Wen-Hung, a researcher at Chang Gung, who was quoted in the Taipei Times.

Researchers like Wen-Hung are asking why.

Read the rest of this entry »

Chinese doctor’s discovery may lead to treatment for SJS

A Chinese dermatologist believes he may have found a human protein that can lead to treatment for the severe and progressive skin disease, Stevens-Johnson Syndrome (SJS), according to the Taipei Times.

Read the rest of this entry »

FDA warns of link between anti-epilepsy drugs and SJS

The U.S. Food and Drug Administration is investigating the possibility that phenytoin and fosphenytoin sodium increase the risk of serious skin reactions, such as Stevens Johnson Syndrome (SJS) and toxic epidermal necrolysis (TEN), according to FDA MedWatch. Phenytoin and fosphenytoin are used to control tonic-clonic (grand mal) and complex-partial seizures in epilepsy.

Read the rest of this entry »